Role of FAT1 in health and disease (Review)
- Authors:
- Zizhen Peng
- Yanyu Gong
- Xiaoqiu Liang
-
Affiliations: Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Cancer Research Institute, Hengyang School of Medicine, University of South China, Hengyang, Hunan 421001, P.R. China - Published online on: March 18, 2021 https://doi.org/10.3892/ol.2021.12659
- Article Number: 398
-
Copyright: © Peng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Haugan K, Marcussen N, Kjølbye A, Nielsen M, Hennan J and Petersen J: Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction. J Cardiovasc Pharmacol. 47:236–242. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuchida S, Arai Y, Kishida T, Takahashi KA, Honjo K, Terauchi R, Inoue H, Oda R, Mazda O and Kubo T: Silencing the expression of connexin 43 decreases inflammation and joint destruction in experimental arthritis. J Orthop Res. 31:525–530. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
El-Bahrawy M, Talbot I, Poulsom R, Jeffery R and Alison M: The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients. J Pathol. 198:69–76. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Nollet F, Kools P and van Roy F: Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol. 299:551–572. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tanoue T and Takeichi M: New insights into Fat cadherins. J Cell Sci. 118:2347–2353. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bryant PJ, Huettner B, Held LI Jr, Ryerse J and Szidonya J: Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila. Dev Biol. 129:541–554. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Sadeqzadeh E, de Bock C and Thorne R: Sleeping giants: Emerging roles for the fat cadherins in health and disease. Med Res Rev. 34:190–221. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bennett F and Harvey K: Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol. 16:2101–2110. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Silva E, Tsatskis Y, Gardano L, Tapon N and McNeill H: The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol. 16:2081–2089. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Oh H and Irvine K: In vivo regulation of Yorkie phosphorylation and localization. Development. 135:1081–1088. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C, Axelrod J and Simon M: Regulation of Frizzled by fat-like cadherins during planar polarity signaling in the Drosophila compound eye. Cell. 108:675–688. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Hill E, Broadbent I, Chothia C and Pettitt J: Cadherin superfamily proteins in caenorhabditis elegans and Drosophila melanogaster. J Mol Biol. 305:1011–1024. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Down M, Power M, Smith SI, Ralston K, Spanevello M, Burns GF and Boyd AW: Cloning and expression of the large zebrafish protocadherin gene, Fat. Gene Expr Patterns. 5:483–490. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q and Cai X: History and progression of Fat cadherins in health and disease. Onco Targets Ther. 9:7337–7343. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Dunne J, Hanby AM, Poulsom R, Jones TA, Sheer D, Chin WG, Da SM, Zhao Q, Beverley PC and Owen MJ: Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics. 30:207–223. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Valletta D, Czech B, Spruss T, Ikenberg K, Wild P, Hartmann A, Weiss TS, Oefner PJ, Müller M, Bosserhoff AK and Hellerbrand C: Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. Carcinogenesis. 35:1407–1415. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sadeqzadeh E, de Bock CE, Zhang XD, Shipman KL, Scott NM, Song C, Yeadon T, Oliveira CS, Jin B, Hersey P, et al: Dual processing of FAT1 cadherin protein by human melanoma cells generates distinct protein products. J Biol Chem. 286:28181–28191. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Schreiner D, Müller K and Hofer H: The intracellular domain of the human protocadherin hFat1 interacts with Homer signalling scaffolding proteins. FEBS Lett. 580:5295–5300. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Morris LGT, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan S, Eng S, Kannan K, Zou Y, Peng L, et al: Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat Genet. 45:253–261. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmed AF, de Bock CE, Lincz LF, Pundavela J, Zouikr I, Sontag E, Hondermarck H and Thorne RF: FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation. Cell Mol Life Sci. 72:4653–4669. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Zhai Y, Kong P, Cui H, Yan T, Yang J, Qian Y, Ma Y, Wang F, Li H, et al: FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer. Cancer Lett. 397:83–93. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Pastushenko I, Mauri F, Song Y, de Cock F, Meeusen B, Swedlund B, Impens F, Van Haver D, Opitz M, Thery M, et al: Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature. 589:448–455. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Mariot V, Roche S, Hourdé C, Portilho D, Sacconi S, Puppo F, Duguez S, Rameau P, Caruso N, Delezoide AL, et al: Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy. Ann Neurol. 78:387–400. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Blair IP, Chetcuti AF, Badenhop RF, Scimone A, Moses MJ, Adams LJ, Craddock N, Green E, Kirov G, Owen MJ, et al: Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol Psychiatry. 11:372–383. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Krause M, Bear J, Loureiro J and Gertler F: The Ena/VASP enigma. J Cell Sci. 115:4721–4726. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Krause M, Leslie JD, Stewart M, Lafuente EM, Valderrama F, Jagannathan R, Strasser GA, Rubinson DA, Liu H, Way M, et al: Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. Dev Cell. 7:571–583. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lafuente EM, van Puijenbroek AFL, Krause M, Carman CV, Freeman GJ, Berezovskaya A, Constantine E, Springer TA, Gertler FB and Boussiotis VA: RIAM, an Ena/VASP and profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell. 7:585–595. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Renfranz P and Beckerle M: Doing (F/L)PPPPs: EVH1 domains and their proline-rich partners in cell polarity and migration. Curr Opin Cell Biol. 14:88–103. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Moeller MJ, Soofi A, Braun GS, Li X, Watzl C, Kriz W and Holzman LB: Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J. 23:3769–3779. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tanoue T and Takeichi M: Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. J Cell Biol. 165:517–528. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Nobes CD and Hall A: Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol. 144:1235–1244. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Huang P, Yan R, Zhang X, Wang L, Ke X and Qu Y: Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities. Pharmacol Ther. 196:79–90. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Nusse R and Clevers H: Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L and Banales JM: Wnt-β-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 16:121–136. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Hou R, Liu L, Anees S, Hiroyasu S and Sibinga NES: The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals. J Cell Biol. 173:417–429. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Clevers H: Wnt/beta-catenin signaling in development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Clevers H and Nusse R: Wnt/β-catenin signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kaplan D, Meigs T and Casey P: Distinct regions of the cadherin cytoplasmic domain are essential for functional interaction with Galpha 12 and beta-catenin. J Biol Chem. 276:44037–44043. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422–426. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJ and Phillips WA: Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J Biol Chem. 276:45113–45119. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kolligs FT, Nieman MT, Winer I, Hu G, Van Mater D, Feng Y, Smith IM, Wu R, Zhai Y, Cho KR and Fearon ER: ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell. 1:145–155. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science. 281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Cancer Genome Atlas Research Network, . Integrated genomic analyses of ovarian carcinoma. Nature. 474:609–615. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Staley B and Irvine K: Hippo signaling in Drosophila: Recent advances and insights. Dev Dyn. 241:3–15. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pan D: The hippo signaling pathway in development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Oh H and Irvine K: Yorkie: The final destination of Hippo signaling. Trends Cell Biol. 20:410–417. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wei X, Shimizu T and Lai Z: Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 26:1772–1781. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
McCartney BM, Kulikauskas RM, LaJeunesse DR and Fehon RG: The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation. Development. 127:1315–1324. 2000.PubMed/NCBI | |
|
Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R and Brummelkamp TR: YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 17:2054–2060. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D: Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 130:1120–1133. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao B, Li L, Lei Q and Guan K: The Hippo-YAP pathway in organ size control and tumorigenesis: An updated version. Genes Dev. 24:862–874. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X and Wrana JL: Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 5:1611–1624. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wrighton K, Dai F and Feng X: A new kid on the TGFbeta block: TAZ controls Smad nucleocytoplasmic shuttling. Dev Cell. 15:8–10. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Nishioka N, Inoue KI, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N, et al: The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell. 16:398–410. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmed A, de Bock C, Sontag E, Hondermarck H, Lincz L and Thorne R: FAT1 cadherin controls neuritogenesis during NTera2 cell differentiation. Biochem Biophys Res Commun. 514:625–631. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Skouloudaki K, Puetz M, Simons M, Courbard JR, Boehlke C, Hartleben B, Engel C, Moeller MJ, Englert C, Bollig F, et al: Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proc Natl Acad Sci USA. 106:8579–8584. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ye CY, Zheng CP, Ying WW and Weng SS: Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1. Cell Cycle. 17:2666–2683. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yan P, Zhu H, Yin L, Wang L, Xie P, Ye J, Jiang X and He X: Integrin αvβ6 promotes lung cancer proliferation and metastasis through upregulation of IL-8-mediated MAPK/ERK signaling. Transl Oncol. 11:619–627. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang WM, Xu Y, Wang YH, Sun HX, Sun YF, He YF, Zhu QF, Hu B, Zhang X, Xia JL, et al: HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Oncotarget. 8:47121–47135. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Miller MB, Bi WL, Ramkissoon LA, Kang YJ, Abedalthagafi M, Knoff DS, Agarwalla PK, Wen PY, Reardon DA, Alexander BM, et al: MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma. Oncotarget. 7:37054–37063. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Wang G, Ma Y, Teng J, Wang Y, Cui Y, Dong Y, Shao S, Zhan Q and Liu X: FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma. Chin J Cancer Res. 31:609–619. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Saxena K, Jolly M and Balamurugan K: Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis. Transl Oncol. 13:1008452020. View Article : Google Scholar : PubMed/NCBI | |
|
Meng P, Zhang YF, Zhang W, Chen X, Xu T, Hu S, Liang X, Feng M, Yang X and Ho M: Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells. Sci Rep. 11:402021. View Article : Google Scholar : PubMed/NCBI | |
|
Srivastava C, Irshad K, Dikshit B, Chattopadhyay P, Sarkar C, Gupta DK, Sinha S and Chosdol K: FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma. Int J Cancer. 142:805–812. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, Van Keymeulen A, Brown D, Moers V, Lemaire S, et al: Identification of the tumour transition states occurring during EMT. Nature. 556:463–468. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ponassi M, Jacques TS, Ciani L and ffrench Constant C: Expression of the rat homologue of the Drosophila fat tumour suppressor gene. Mech Dev. 80:207–212. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Ciani L, Patel A, Allen N and ffrench-Constant C: Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol. 23:3575–3582. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Inoue T, Yaoita E, Kurihara H, Shimizu F, Sakai T, Kobayashi T, Ohshiro K, Kawachi H, Okada H, Suzuki H, et al: FAT is a component of glomerular slit diaphragms. Kidney Int. 59:1003–1012. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Yaoita E, Kurihara H, Yoshida Y, Inoue T, Matsuki A, Sakai T and Yamamoto T: Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney. Kidney Int. 68:542–551. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC and George SJ: Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res. 92:1314–1321. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lahrouchi N, George A, Ratbi I, Schneider R, Elalaoui SC, Moosa S, Bharti S, Sharma R, Abu-Asab M, Onojafe F, et al: Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly. Nat Commun. 10:11802019. View Article : Google Scholar : PubMed/NCBI | |
|
Puppo F, Dionnet E, Gaillard MC, Gaildrat P, Castro C, Vovan C, Bertaux K, Bernard R, Attarian S, Goto K, et al: Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype. Hum Mutat. 36:443–453. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Park HJ, Lee W, Kim SH, Lee JH, Shin HY, Kim SM, Park KD, Lee JH and Choi YC: FAT1 gene alteration in facioscapulohumeral muscular dystrophy type 1. Yonsei Med J. 59:337–340. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Caruso N, Herberth B, Bartoli M, Puppo F, Dumonceaux J, Zimmermann A, Denadai S, Lebossé M, Roche S, Geng L, et al: Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet. 9:e10035502013. View Article : Google Scholar : PubMed/NCBI | |
|
Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, et al: Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 51:793–803. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Electronic address: douglas.ruderfer@vanderbilt.edu; Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium: Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes, . Cell. 173:1705–1715.e1716. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Psychiatric GWAS Consortium Bipolar Disorder Working Group, : Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 43:977–983. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Abou Jamra R, Becker T, Georgi A, Feulner T, Schumacher J, Stromaier J, Schirmbeck F, Schulze TG, Propping P, Rietschel M, et al: Genetic variation of the FAT gene at 4q35 is associated with bipolar affective disorder. Mol Psychiatry. 13:277–284. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Neumann M, Seehawer M, Schlee C, Vosberg S, Heesch S, von der Heide EK, Graf A, Krebs S, Blum H, Gökbuget N, et al: FAT1 expression and mutations in adult acute lymphoblastic leukemia. Blood Cancer J. 4:e2242014. View Article : Google Scholar : PubMed/NCBI | |
|
de Bock CE, Ardjmand A, Molloy TJ, Bone SM, Johnstone D, Campbell DM, Shipman KL, Yeadon TM, Holst J, Spanevello MD, et al: The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. Leukemia. 26:918–926. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
GBD 2015 Mortality and Causes of Death Collaborators, . Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the global burden of disease study 2015. Lancet. 388:1459–1544. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W and Taylor-Robinson SD: Hepatocellular carcinoma: Current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 3:353–367. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Dhanasekaran R, Limaye A and Cabrera R: Hepatocellular carcinoma: Current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 4:19–37. 2012.PubMed/NCBI | |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bataller R and Brenner D: Liver fibrosis. J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Farazi P and DePinho R: Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer. 6:674–687. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rosmorduc O and Housset C: Hypoxia: A link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis. 30:258–270. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Argiris A, Karamouzis M, Raben D and Ferris R: Head and neck cancer. Lancet. 371:1695–1709. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Pai SI and Westra WH: Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 4:49–70. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kim KT, Kim BS and Kim JH: Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma. Head Neck. 38 (Suppl 1):S2021–S2029. 2016. View Article : Google Scholar | |
|
Gupta S, Kong W, Peng Y, Miao Q and Mackillop W: Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. Int J Cancer. 125:2159–2165. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lin SC, Lin LH, Yu SY, Kao SY, Chang KW, Cheng HW and Liu CJ: FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival. Carcinogenesis. 39:1320–1330. 2018.PubMed/NCBI | |
|
Katoh Y and Katoh M: Comparative integromics on FAT1, FAT2, FAT3 and FAT4. Int J Mol Med. 18:523–528. 2006.PubMed/NCBI | |
|
Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW and Lin SC: Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol. 214:489–497. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Martin D, Degese MS, Vitale-Cross L, Iglesias-Bartolome R, Valera JLC, Wang Z, Feng X, Yeerna H, Vadmal V, Moroishi T, et al: Assembly and activation of the Hippo signalome by FAT1 tumor suppressor. Nat Commun. 9:23722018. View Article : Google Scholar : PubMed/NCBI | |
|
Pennathur A, Gibson M, Jobe B and Luketich J: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X, Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 509:91–95. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, Mark SD, Qiao YL and Taylor PR: Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 113:456–463. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y and Muto M: Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li WQ, Park Y, Wu JW, Ren JS, Goldstein AM, Taylor PR, Hollenbeck AR, Freedman ND and Abnet CC: Index-based dietary patterns and risk of esophageal and gastric cancer in a large cohort study. Clin Gastroenterol Hepatol. 11:1130–1136.e1132. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Li Y, Chen W, Song B, et al: Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 96:597–611. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Sauer AG, Jemal A and Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Britt KL, Cuzick J and Phillips KA: Key steps for effective breast cancer prevention. Nat Rev Cancer. 20:417–436. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Lyu S, Wang S, Shen H, Niu F, Liu X, Liu J and Niu Y: Loss of FAT1 during the progression from DCIS to IDC and predict poor clinical outcome in breast cancer. Exp Mol Pathol. 100:177–183. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, Colditz G, Medina D and Allred DC: Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res. 72:4574–4586. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Guo L, Qi J, Wang H, Jiang X and Liu Y: Getting under the skin: The role of CDK4/6 in melanomas. Eur J Med Chem. 204:1125312020. View Article : Google Scholar : PubMed/NCBI | |
|
Salvador-Barbero B, Álvarez-Fernández M, Zapatero-Solana E, El Bakkali A, Menéndez MDC, López-Casas PP, Di Domenico T, Xie T, VanArsdale T, Shields DJ, et al: CDK4/6 inhibitors impair recovery from cytotoxic chemotherapy in pancreatic adenocarcinoma. Cancer Cell. 37:340–353.e346. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Razavi P, Li Q, Toy W, Liu B, Ping C, Hsieh W, Sanchez-Vega F, Brown DN, Da Cruz Paula AF, et al: Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the hippo pathway. Cancer Cell. 34:893–905.e898. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS and Park YY: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1. Oncotarget. 8:98887–98897. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Döhner H, Bloomfield C, Frizzera G, Frestedt J and Arthur D: Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosomes Cancer. 5:392–398. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Yu J and Li H: The expression of FAT1 is associated with overall survival in children with medulloblastoma. Tumori. 103:44–52. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Polascik TJ, Cairns P, Chang WY, Schoenberg MP and Sidransky D: Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res. 55:5396–5399. 1995.PubMed/NCBI | |
|
Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, Minna JD and Gazdar AF: Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res. 5:17–23. 1999.PubMed/NCBI | |
|
Shivapurkar N, Maitra A, Milchgrub S and Gazdar AF: Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum Pathol. 32:169–177. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M, Sun X, Wang Y, Ling K, Chen C, Cai X, Liang X and Liang Z: FAT1 inhibits the proliferation and metastasis of cervical cancer cells by binding β-catenin. Int J Clin Exp Pathol. 12:3807–3818. 2019.PubMed/NCBI | |
|
Zhang H, Ramakrishnan SK, Triner D, Centofanti B, Maitra D, Győrffy B, Sebolt-Leopold JS, Dame MK, Varani J, Brenner DE, et al: Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Sci Signal. 8:ra982015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Wang B, Liu ZT, Lai MC, Zhang ML and Zheng SS: miR-223-3p regulating the occurrence and development of liver cancer cells by targeting FAT1 gene. Math Biosci Eng. 17:1534–1547. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fan L, Campagnoli S, Wu H, Grandi A, Parri M, De Camilli E, Grandi G, Viale G, Pileri P, Grifantini R, et al: Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting. J Exp Clin Cancer Res. 34:1032015. View Article : Google Scholar : PubMed/NCBI | |
|
Katoh M: Function and cancer genomics of FAT family genes (review). Int J Oncol. 41:1913–1918. 2012. View Article : Google Scholar : PubMed/NCBI |
